Seqens Seqens

X

Find the latest Drugs in Development and Pipeline Prospector News of Tianjin Tiancheng Pharma. Co Ltd.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Tianjin Tiancheng Pharma. Co., Ltd.
China Flag
Country
Country
China
Address
Address
No.9 Liuming Road Yangliuqing Xiqing District
Telephone
Telephone
86 222 792 1126
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

This acquisition will significantly reinforce Grifols’ industry capabilities by enhancing its plasmaderived medicines access, pipeline Biotest is leading clinical trials on plasma-derived fibrinogen (BT524) to treat congenital and acquired disorders.


Lead Product(s): BT524

Therapeutic Area: Genetic Disease Product Name: BT524

Highest Development Status: Phase IIIProduct Type: Large molecule

Partner/Sponsor/Collaborator: Grifols International

Deal Size: $1,281.5 million Upfront Cash: Undisclosed

Deal Type: Acquisition September 17, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY